位置:首页 > 蛋白库 > TYW1_HUMAN
TYW1_HUMAN
ID   TYW1_HUMAN              Reviewed;         732 AA.
AC   Q9NV66; Q6PJG8; Q75MG8; Q75MN3; Q86V12; Q8IVS7; Q9H9C4;
DT   03-APR-2007, integrated into UniProtKB/Swiss-Prot.
DT   03-APR-2007, sequence version 2.
DT   03-AUG-2022, entry version 151.
DE   RecName: Full=S-adenosyl-L-methionine-dependent tRNA 4-demethylwyosine synthase TYW1;
DE            EC=4.1.3.44;
DE   AltName: Full=Radical S-adenosyl methionine and flavodoxin domain-containing protein 1;
DE   AltName: Full=tRNA wybutosine-synthesizing protein 1 homolog;
DE   AltName: Full=tRNA-yW-synthesizing protein;
GN   Name=TYW1; Synonyms=RSAFD1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANTS ARG-632
RP   AND ASN-671.
RC   TISSUE=Teratocarcinoma;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R., Wylie K.,
RA   Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E., Fewell G.A.,
RA   Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H., Sun H.,
RA   Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A., Vanbrunt A.,
RA   Nguyen C., Du F., Lamar B., Courtney L., Kalicki J., Ozersky P.,
RA   Bielicki L., Scott K., Holmes A., Harkins R., Harris A., Strong C.M.,
RA   Hou S., Tomlinson C., Dauphin-Kohlberg S., Kozlowicz-Reilly A., Leonard S.,
RA   Rohlfing T., Rock S.M., Tin-Wollam A.-M., Abbott A., Minx P., Maupin R.,
RA   Strowmatt C., Latreille P., Miller N., Johnson D., Murray J.,
RA   Woessner J.P., Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W.,
RA   Spieth J., Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E.,
RA   Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Bedell J.A.,
RA   Mardis E.R., Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K., Simms E.,
RA   Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S., Baertsch R.A.,
RA   Brent M.R., Keibler E., Flicek P., Bork P., Suyama M., Bailey J.A.,
RA   Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R., Eddy S.R.,
RA   McPherson J.D., Olson M.V., Eichler E.E., Green E.D., Waterston R.H.,
RA   Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Colon, Placenta, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: Probable component of the wybutosine biosynthesis pathway.
CC       Wybutosine is a hyper modified guanosine with a tricyclic base found at
CC       the 3'-position adjacent to the anticodon of eukaryotic phenylalanine
CC       tRNA. Catalyzes the condensation of N-methylguanine with 2 carbon atoms
CC       from pyruvate to form the tricyclic 4-demethylwyosine, an intermediate
CC       in wybutosine biosynthesis (By similarity). {ECO:0000250}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=N(1)-methylguanosine(37) in tRNA(Phe) + pyruvate + S-adenosyl-
CC         L-methionine = 4-demethylwyosine(37) in tRNA(Phe) + 5'-deoxyadenosine
CC         + CO2 + H2O + L-methionine; Xref=Rhea:RHEA:36347, Rhea:RHEA-
CC         COMP:10164, Rhea:RHEA-COMP:10165, ChEBI:CHEBI:15361,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:16526, ChEBI:CHEBI:17319,
CC         ChEBI:CHEBI:57844, ChEBI:CHEBI:59789, ChEBI:CHEBI:64315,
CC         ChEBI:CHEBI:73542; EC=4.1.3.44;
CC   -!- COFACTOR:
CC       Name=[4Fe-4S] cluster; Xref=ChEBI:CHEBI:49883; Evidence={ECO:0000250};
CC       Note=Binds 1 [4Fe-4S] cluster. The cluster is coordinated with 3
CC       cysteines and an exchangeable S-adenosyl-L-methionine. {ECO:0000250};
CC   -!- PATHWAY: tRNA modification; wybutosine-tRNA(Phe) biosynthesis.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9NV66-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9NV66-2; Sequence=VSP_024066, VSP_024067;
CC   -!- SIMILARITY: Belongs to the TYW1 family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH15591.1; Type=Frameshift; Evidence={ECO:0000305};
CC       Sequence=BAB14307.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK001762; BAA91891.1; -; mRNA.
DR   EMBL; AK022917; BAB14307.1; ALT_INIT; mRNA.
DR   EMBL; AC079920; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC006480; AAS07568.1; -; Genomic_DNA.
DR   EMBL; AC073089; AAS07520.1; -; Genomic_DNA.
DR   EMBL; BC015591; AAH15591.1; ALT_FRAME; mRNA.
DR   EMBL; BC042156; AAH42156.1; ALT_TERM; mRNA.
DR   EMBL; BC051888; AAH51888.1; -; mRNA.
DR   CCDS; CCDS5538.1; -. [Q9NV66-1]
DR   RefSeq; NP_060734.2; NM_018264.3. [Q9NV66-1]
DR   AlphaFoldDB; Q9NV66; -.
DR   SMR; Q9NV66; -.
DR   BioGRID; 120544; 126.
DR   IntAct; Q9NV66; 33.
DR   STRING; 9606.ENSP00000352645; -.
DR   iPTMnet; Q9NV66; -.
DR   PhosphoSitePlus; Q9NV66; -.
DR   BioMuta; TYW1; -.
DR   DMDM; 143678193; -.
DR   EPD; Q9NV66; -.
DR   jPOST; Q9NV66; -.
DR   MassIVE; Q9NV66; -.
DR   MaxQB; Q9NV66; -.
DR   PaxDb; Q9NV66; -.
DR   PeptideAtlas; Q9NV66; -.
DR   PRIDE; Q9NV66; -.
DR   ProteomicsDB; 82752; -. [Q9NV66-1]
DR   ProteomicsDB; 82753; -. [Q9NV66-2]
DR   Antibodypedia; 2749; 72 antibodies from 21 providers.
DR   DNASU; 55253; -.
DR   Ensembl; ENST00000359626.10; ENSP00000352645.5; ENSG00000198874.14. [Q9NV66-1]
DR   Ensembl; ENST00000361660.8; ENSP00000354795.4; ENSG00000198874.14. [Q9NV66-2]
DR   GeneID; 55253; -.
DR   KEGG; hsa:55253; -.
DR   MANE-Select; ENST00000359626.10; ENSP00000352645.5; NM_018264.4; NP_060734.2.
DR   UCSC; uc003tvn.5; human. [Q9NV66-1]
DR   CTD; 55253; -.
DR   DisGeNET; 55253; -.
DR   GeneCards; TYW1; -.
DR   HGNC; HGNC:25598; TYW1.
DR   HPA; ENSG00000198874; Low tissue specificity.
DR   MIM; 611243; gene.
DR   neXtProt; NX_Q9NV66; -.
DR   OpenTargets; ENSG00000198874; -.
DR   PharmGKB; PA134940167; -.
DR   VEuPathDB; HostDB:ENSG00000198874; -.
DR   eggNOG; KOG1160; Eukaryota.
DR   GeneTree; ENSGT00510000047059; -.
DR   HOGENOM; CLU_007952_2_0_1; -.
DR   InParanoid; Q9NV66; -.
DR   OMA; WMLGARR; -.
DR   OrthoDB; 731783at2759; -.
DR   PhylomeDB; Q9NV66; -.
DR   TreeFam; TF300773; -.
DR   PathwayCommons; Q9NV66; -.
DR   Reactome; R-HSA-6782861; Synthesis of wybutosine at G37 of tRNA(Phe).
DR   SignaLink; Q9NV66; -.
DR   UniPathway; UPA00375; -.
DR   BioGRID-ORCS; 55253; 14 hits in 1041 CRISPR screens.
DR   ChiTaRS; TYW1; human.
DR   GenomeRNAi; 55253; -.
DR   Pharos; Q9NV66; Tbio.
DR   PRO; PR:Q9NV66; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   RNAct; Q9NV66; protein.
DR   Bgee; ENSG00000198874; Expressed in sural nerve and 100 other tissues.
DR   ExpressionAtlas; Q9NV66; baseline and differential.
DR   Genevisible; Q9NV66; HS.
DR   GO; GO:0051539; F:4 iron, 4 sulfur cluster binding; IEA:UniProtKB-KW.
DR   GO; GO:0010181; F:FMN binding; IEA:InterPro.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0102521; F:tRNA-4-demethylwyosine synthase activity; IEA:UniProtKB-EC.
DR   GO; GO:0031591; P:wybutosine biosynthetic process; IBA:GO_Central.
DR   Gene3D; 3.20.20.70; -; 1.
DR   Gene3D; 3.40.50.360; -; 1.
DR   InterPro; IPR013785; Aldolase_TIM.
DR   InterPro; IPR001094; Flavdoxin-like.
DR   InterPro; IPR008254; Flavodoxin/NO_synth.
DR   InterPro; IPR029039; Flavoprotein-like_sf.
DR   InterPro; IPR007197; rSAM.
DR   InterPro; IPR013917; tRNA_wybutosine-synth.
DR   InterPro; IPR034556; tRNA_wybutosine-synthase.
DR   PANTHER; PTHR13930; PTHR13930; 1.
DR   Pfam; PF00258; Flavodoxin_1; 1.
DR   Pfam; PF04055; Radical_SAM; 1.
DR   Pfam; PF08608; Wyosine_form; 1.
DR   PRINTS; PR00369; FLAVODOXIN.
DR   SFLD; SFLDS00029; Radical_SAM; 1.
DR   SFLD; SFLDF00284; tRNA_wybutosine-synthesizing; 1.
DR   SUPFAM; SSF52218; SSF52218; 1.
DR   PROSITE; PS50902; FLAVODOXIN_LIKE; 1.
DR   PROSITE; PS51918; RADICAL_SAM; 1.
PE   2: Evidence at transcript level;
KW   4Fe-4S; Alternative splicing; Iron; Iron-sulfur; Lyase; Metal-binding;
KW   Nucleotide-binding; Reference proteome; S-adenosyl-L-methionine;
KW   tRNA processing.
FT   CHAIN           1..732
FT                   /note="S-adenosyl-L-methionine-dependent tRNA 4-
FT                   demethylwyosine synthase TYW1"
FT                   /id="PRO_0000281826"
FT   DOMAIN          79..237
FT                   /note="Flavodoxin-like"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00088"
FT   DOMAIN          400..644
FT                   /note="Radical SAM core"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01266"
FT   REGION          248..314
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        256..290
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         85..89
FT                   /ligand="FMN"
FT                   /ligand_id="ChEBI:CHEBI:58210"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00088"
FT   BINDING         176..208
FT                   /ligand="FMN"
FT                   /ligand_id="ChEBI:CHEBI:58210"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00088"
FT   BINDING         416
FT                   /ligand="[4Fe-4S] cluster"
FT                   /ligand_id="ChEBI:CHEBI:49883"
FT                   /ligand_note="4Fe-4S-S-AdoMet"
FT                   /evidence="ECO:0000255"
FT   BINDING         420
FT                   /ligand="[4Fe-4S] cluster"
FT                   /ligand_id="ChEBI:CHEBI:49883"
FT                   /ligand_note="4Fe-4S-S-AdoMet"
FT                   /evidence="ECO:0000255"
FT   BINDING         423
FT                   /ligand="[4Fe-4S] cluster"
FT                   /ligand_id="ChEBI:CHEBI:49883"
FT                   /ligand_note="4Fe-4S-S-AdoMet"
FT                   /evidence="ECO:0000255"
FT   VAR_SEQ         368..384
FT                   /note="GYQLIGSHSGVKLCRWT -> VHAPRERRLLQTHILWN (in isoform
FT                   2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_024066"
FT   VAR_SEQ         385..732
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_024067"
FT   VARIANT         462
FT                   /note="G -> V (in dbSNP:rs2261015)"
FT                   /id="VAR_031288"
FT   VARIANT         632
FT                   /note="H -> R (in dbSNP:rs2949097)"
FT                   /evidence="ECO:0000269|PubMed:14702039"
FT                   /id="VAR_031289"
FT   VARIANT         671
FT                   /note="D -> N (in dbSNP:rs28450001)"
FT                   /evidence="ECO:0000269|PubMed:14702039"
FT                   /id="VAR_031290"
FT   CONFLICT        382
FT                   /note="R -> M (in Ref. 1; BAB14307)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        388
FT                   /note="L -> F (in Ref. 1; BAB14307)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        416
FT                   /note="C -> Y (in Ref. 1; BAB14307)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        543
FT                   /note="K -> R (in Ref. 1; BAB14307)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   732 AA;  83702 MW;  95E8E5C3F88ADD23 CRC64;
     MDPSADTWDL FSPLISLWIN RFYIYLGFAV SISLWICVQI VIKTQGKNLQ EKSVPKAAQD
     LMTNGYVSLQ EKDIFVSGVK IFYGSQTGTA KGFATVLAEA VTSLDLPVAI INLKEYDPDD
     HLIEEVTSKN VCVFLVATYT DGLPTESAEW FCKWLEEASI DFRFGKTYLK GMRYAVFGLG
     NSAYASHFNK VGKNVDKWLW MLGAHRVMSR GEGDCDVVKS KHGSIEADFR AWKTKFISQL
     QALQKGERKK SCGGHCKKGK CESHQHGSEE REEGSHEQDE LHHRDTEEEE PFESSSEEEF
     GGEDHQSLNS IVDVEDLGKI MDHVKKEKRE KEQQEEKSGL FRNMGRNEDG ERRAMITPAL
     REALTKQGYQ LIGSHSGVKL CRWTKSMLRG RGGCYKHTFY GIESHRCMET TPSLACANKC
     VFCWRHHTNP VGTEWRWKMD QPEMILKEAI ENHQNMIKQF KGVPGVKAER FEEGMTVKHC
     ALSLVGEPIM YPEINRFLKL LHQCKISSFL VTNAQFPAEI RNLEPVTQLY VSVDASTKDS
     LKKIDRPLFK DFWQRFLDSL KALAVKQQRT VYRLTLVKAW NVDELQAYAQ LVSLGNPDFI
     EVKGVTYCGE SSASSLTMAH VPWHEEVVQF VHELVDLIPE YEIACEHEHS NCLLIAHRKF
     KIGGEWWTWI DYNRFQELIQ EYEDSGGSKT FSAKDYMART PHWALFGASE RGFDPKDTRH
     QRKNKSKAIS GC
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2025